Copyright
©The Author(s) 2020.
World J Clin Cases. Dec 26, 2020; 8(24): 6315-6321
Published online Dec 26, 2020. doi: 10.12998/wjcc.v8.i24.6315
Published online Dec 26, 2020. doi: 10.12998/wjcc.v8.i24.6315
Table 1 General data of 30 patients
| Patient characteristics | n (%) |
| Gender | |
| Males | 29 (96.7%) |
| Female | 1 (3.3%) |
| Median age (range), yr | 55 (48-70) |
| Clinical stage | |
| I | 0 |
| II | 3 (10%) |
| III | 27 (90%) |
| IV | 0 |
| Tumor location | |
| Upper chest | 0 |
| Middle chest | 4 (21.0%) |
| Lower chest | 26 (86.7%) |
Table 2 Pathological grading before and after surgery
| Stage | Preoperative grade, n (%) | Postoperative grade, n (%) |
| 0 | 0 | 10 (52.6) |
| I | 0 | 6 (36.8) |
| II | 3 (10) | 1 (53.3) |
| III | 16 (90) | 9 (30) |
| IV | 0 | 0 |
- Citation: Yan MH, Hou XB, Cai BN, Qu BL, Dai XK, Liu F. Neoadjuvant chemoradiotherapy plus surgery in the treatment of potentially resectable thoracic esophageal squamous cell carcinoma. World J Clin Cases 2020; 8(24): 6315-6321
- URL: https://www.wjgnet.com/2307-8960/full/v8/i24/6315.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i24.6315
